Safety and Immunogenicity of COVID-19 Vaccine in Population Aged 18 Years and Above

NCT05552573 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: low-dose LYB001
BIOLOGICAL: Recombinant COVID-19 Vaccine (CHO Cell)
BIOLOGICAL: high-dose LYB001

Sponsor

Guangzhou Patronus Biotech Co., Ltd.

Collaborators

[object Object]